FDA Import Refusal 1FX-1623982-5/60002/1 — HEGDE & HEGDE PHARMACEUTICAL
The FDA refused shipment 1FX-1623982-5/60002/1 from HEGDE & HEGDE PHARMACEUTICAL (India) on Oct 8, 2026. The refused product falls under Drugs and Biologics — RABEPRAZOLE SODIUM (ANTACID) (ANTI-ULCER). Cited charge: 75 This firm has 3 other import refusals on record.
Refusal Details
- Date
- Oct 8, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60SCA27 RABEPRAZOLE SODIUM (ANTACID) (ANTI-ULCER)
- Charges
- 75